BVF Inc/il, 10% Owner, Director at INFINITY PHARMACEUTICALS, INC. (INFI), bought 1,266,820 shares at $1.28 ($1.7M) on 2016-12-16, disclosed to the SEC on 2016-12-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.28 | 47,812 | $61K | 3.7% |
| 2 | $1.28 | 47,812 | $61K | 3.7% |
| 3 | $1.28 | 150,451 | $193K | 11.6% |
| 4 | $1.28 | 150,451 | $193K | 11.6% |
| 5 | $1.28 | 236,393 | $303K | 18.3% |
| 6 | $1.28 | 236,393 |
| $303K |
| 18.3% |
| 7 | $1.36 | 21,021 | $29K | 1.7% |
| 8 | $1.36 | 69,041 | $94K | 5.7% |
| 9 | $1.36 | 69,041 | $94K | 5.7% |
| 10 | $1.36 | 108,202 | $147K | 8.9% |
| 11 | $1.36 | 108,202 | $147K | 8.9% |
| 12 | $1.35 | 2,244 | $3K | 0.2% |
| 13 | $1.35 | 8,111 | $11K | 0.7% |
| 14 | $1.35 | 11,646 | $16K | 1.0% |
| Total | $1.30 avg | 1,266,820 | $1.7M | 100% |
| Filing → |
| PNT | SELL | 2023-12-20 | $427.3M | — | Filing → |
| CGEM | BUY | 2022-05-16 | $20.1M | — | Filing → |
| KYMR | BUY | 2022-05-09 | $8.3M | — | Filing → |